Birgit L.M.G. Senden-Gijsbers

Author

Also Known As

B Senden-Gijsbers, B.L.M.G. Senden-Gijsbers, Birgit L M G Senden-Gijsbers, Birgit L. M. G. Senden-Gijsbers, Birgit L. M. G. Senden‐Gijsbers, Birgit L.M.G. Senden-Gijsbers

Publications

595

Citations

H-Index

Concepts

All Affiliations

Maastricht University Maastricht University Medical Centre Maastro Clinic Pierre Fabre (France)University of Copenhagen

About

Birgit L.M.G. Senden-Gijsbers is an author at Maastricht University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	264
2	Immunology	6	6	254
3	Cell Biology	4	4	156
4	Natural Sciences	1	1	10
5	Molecular Biology	1	1	10

Birgit L.M.G. Senden-Gijsbers

Publications

577

Citations

H-Index

Page 1

	Year	Citations
Technical Advance: Ascorbic acid induces development of double-positive T cells from human hematopoietic stem cells in the absence of stromal cells Mirelle J.A.J. Huijskens, Mateusz Walczak, Nicole Koller, Journal of Leukocyte Biology	2014	104
Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy Mirelle J.A.J. Huijskens, Mateusz Walczak, Subhashis Sarkar, Cytotherapy Ascorbic AcidCulture SystemsImmunologyCell CultureCell Transplantation	2015	85
Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents Arthur Kmit, Roger van Kruchten, Jiraporn Ousingsawat, Cell Death and Disease	2013	72
Inflammation restraining effects of prostaglandin E2 on natural killer–dendritic cell (NK-DC) interaction are imprinted during DC maturation Catharina Van Elssen, Joris Vanderlocht, Tammy Oth, Blood	2011	62
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response Thomas H. P. M. Habets, Tammy Oth, Ans W. Houben, PLoS ONE ImmunologyPathologyImmunologic MechanismImmune InfiltrateImmunotherapy	2016	53
Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma Silvie Cloosen, Jan‐Willem Gratama, E.B.M. van Leeuwen, British Journal of Haematology Hematological MalignancyTumor BiologyPlasma CellsDifferent Glycosylation ProfilesMedicine	2006	45
<i>Klebsiella pneumoniae</i>‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells Catharina Van Elssen, Joris Vanderlocht, Peter Frings, European Journal of Immunology Ccr5‐dependent MannerMicrobial PathogensAdaptive Immune SystemInnate Immune SystemImmunology	2010	39
Combination of radiotherapy with the immunocytokine L19-IL2: Additive effect in a NK cell dependent tumour model Nicolle H. Rekers, Catharina M.L. Zegers, Ala Yaromina, Radiotherapy and Oncology	2015	36
Increased Tumor-Specific CD8<sup>+</sup> T Cell Induction by Dendritic Cells Matured with a Clinical Grade TLR-Agonist in Combination with IFN-γ Joris Vanderlocht, Catharina Van Elssen, Birgit L.M.G. Senden-Gijsbers, International Journal of Immunopathology and Pharmacology	2010	23
Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector E.B.M. van Leeuwen, Silvie Cloosen, Birgit L.M.G. Senden-Gijsbers, Cytotherapy Tumor BiologyHuman DcTumor Mucin-1Oncogenic AgentFiber-modified Adenoviral Vector	2006	17

Page 1